Figure 2From: CD40 mutant expression and its clinical significance to prognosis in gastric cancer patientsOverall survival curves for gastric cancer patients. The median overall survival time of cases with negative CD40 mutant expression is significantly longer than that of cases with positive negative CD40 mutant expression (40 vs. 14 months, 95% CI 30.6-49.4 and 6.7-21.3, respectively, χ2 = 14.229, P <0.001).Back to article page